Literature DB >> 8342253

Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.

S Yamaguchi1, T Yoshioka, M Utsunomiya, T Koide, M Osafune, A Okuyama, T Sonoda.   

Abstract

The nature of the soluble stone matrix and its possible role in urinary stone formation was studied. For this purpose we performed two-dimensional cellulose acetate membrane electrophoresis of the glycosaminoglycans (GAGs) which were contained in the soluble stone matrix, substances adsorbed onto calcium oxalate crystals in vitro (crystal surface binding substances, CSBS) and urinary macromolecules (UMMs). The main GAG in the soluble stone matrix and CSBS was found to be heparan sulfate, whereas the UMMs contained various GAGs usually seen in urine. An inhibition assay showed the soluble stone matrix to have the strongest inhibitory activity among these macromolecular substances when inhibitory activity was expressed in terms of uronic acid concentration. It is suggested that the main GAG in the soluble stone matrix consists of heparan sulfate, which has a strong inhibitory activity on calcium oxalate crystal growth and aggregation and constitutes part of the CSBS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342253     DOI: 10.1007/bf00590035

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  19 in total

1.  Stone matrix and mucoprotein from urine.

Authors:  B FINLAYSON; C W VERMEULEN; E J STEWART
Journal:  J Urol       Date:  1961-10       Impact factor: 7.450

2.  Urinary crystal surface binding substances on calcium oxalate crystals.

Authors:  T Koide; T Yoshioka; S Yamaguchi; S Hosokawa; M Utsunomiya; T Sonoda
Journal:  Urol Res       Date:  1990

3.  A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization.

Authors:  R M Morse; M I Resnick
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

4.  A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis.

Authors:  R Hata; Y Nagai
Journal:  Anal Biochem       Date:  1972-02       Impact factor: 3.365

5.  Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?

Authors:  J C Gjaldbaek; W G Robertson
Journal:  Clin Chim Acta       Date:  1980-11-20       Impact factor: 3.786

6.  Inhibitory effects of urinary calcium-binding substances on calcium oxalate crystallization.

Authors:  M I Resnick; M E Sorrell; J A Bailey; W H Boyce
Journal:  J Urol       Date:  1982-03       Impact factor: 7.450

7.  Surface interaction between glycosaminoglycans and calcium oxalate.

Authors:  A H Angell; M I Resnick
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

8.  Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.

Authors:  Y Nakagawa; M Ahmed; S L Hall; S Deganello; F L Coe
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

9.  Glycosaminoglycans content of stone matrix.

Authors:  S D Roberts; M I Resnick
Journal:  J Urol       Date:  1986-05       Impact factor: 7.450

10.  Matrix glycosaminoglycan in urinary stones.

Authors:  S Nishio; Y Abe; A Wakatsuki; H Iwata; K Ochi; M Takeuchi; A Matsumoto
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

View more
  6 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.

Authors:  Cary A Kuliasha; Douglas Rodriguez; Archana Lovett; Laurie B Gower
Journal:  CrystEngComm       Date:  2020-02-05       Impact factor: 3.545

Review 3.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Protective role of heparin/heparan sulfate on oxalate-induced changes in cell morphology and intracellular Ca2+.

Authors:  Shizuka Iida; Masaru Ishimatsu; Shyumei Chikama; Michiro Inoue; Kei Matsuoka; Takashi Akasu; Shinshi Noda; Saeed R Khan
Journal:  Urol Res       Date:  2003-04-29

Review 5.  Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones.

Authors:  E R Boevé; L C Cao; C F Verkoelen; J C Romijn; W C de Bruijn; F H Schröder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 6.  Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.

Authors:  Kanu Priya Aggarwal; Shifa Narula; Monica Kakkar; Chanderdeep Tandon
Journal:  Biomed Res Int       Date:  2013-09-14       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.